<p>&quot;Xylazine, Nitazenes, and the Changing Street Drug Landscape: What Pain Physicians Should Know&quot; From ASRA Pain Medicine News, February 2026. See the original article at <a href='https://asra.com/news-publications/asra-newsletter/february-2026/newsletter-article/asra-news/2026/02/09/xylazine--nitazenes--and-the-changing-street-drug-landscape--what-pain-physicians-should-know'>www.asra.com/february26news</a> for figures and references. This material is copyrighted.</p><p><a rel="payment" href="https://www.asra.com/about-asra/donate">Support the show</a></p>

<description>&lt;p&gt;&amp;quot;Xylazine, Nitazenes, and the Changing Street Drug Landscape: What Pain Physicians Should Know&amp;quot; From ASRA Pain Medicine News, February 2026. See the original article at &lt;a href='https://asra.com/news-publications/asra-newsletter/february-2026/newsletter-article/asra-news/2026/02/09/xylazine--nitazenes--and-the-changing-street-drug-landscape--what-pain-physicians-should-know'&gt;www.asra.com/february26news&lt;/a&gt; for figures and references. This material is copyrighted.&lt;/p&gt;&lt;p&gt;&lt;a rel="payment" href="https://www.asra.com/about-asra/donate"&gt;Support the show&lt;/a&gt;&lt;/p&gt;</description>

"Xylazine, Nitazenes, and the Changing Street Drug Landscape: What Pain Physicians Should Know" From ASRA Pain Medicine News, February 2026. See the original article at www.asra.com/february26news for figures and references. This material is copyrighted. Support the show 

Xylazine, Nitazenes, and the Changing Street Drug Landscape: What Pain Physicians Should Know

Description